Compile Data Set for Download or QSAR
Report error Found 60 Enz. Inhib. hit(s) with all data for entry = 12384
TargetCyclin-dependent kinase 7(Human)
Yungjin Pharm.

US Patent
LigandChemical structure of BindingDB Monomer ID 699691BDBM699691(US12110299, Example 124)
Affinity DataIC50: 4.5nMAssay Description:Representative compounds of the present invention were assayed in vitro for CDK7 kinase-inhibitory activities using ADP-Glo platform. In detail, CDK7...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2025
Entry Details
US Patent

TargetCyclin-dependent kinase 7(Human)
Yungjin Pharm.

US Patent
LigandChemical structure of BindingDB Monomer ID 699690BDBM699690(US12110299, Example 123)
Affinity DataIC50: 5.30nMAssay Description:Representative compounds of the present invention were assayed in vitro for CDK7 kinase-inhibitory activities using ADP-Glo platform. In detail, CDK7...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2025
Entry Details
US Patent

TargetCyclin-dependent kinase 7(Human)
Yungjin Pharm.

US Patent
LigandChemical structure of BindingDB Monomer ID 699660BDBM699660(US12110299, Example 110)
Affinity DataIC50: 5.90nMAssay Description:Representative compounds of the present invention were assayed in vitro for CDK7 kinase-inhibitory activities using ADP-Glo platform. In detail, CDK7...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2025
Entry Details
US Patent

TargetCyclin-dependent kinase 7(Human)
Yungjin Pharm.

US Patent
LigandChemical structure of BindingDB Monomer ID 699689BDBM699689(US12110299, Example 122)
Affinity DataIC50: 6nMAssay Description:Representative compounds of the present invention were assayed in vitro for CDK7 kinase-inhibitory activities using ADP-Glo platform. In detail, CDK7...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2025
Entry Details
US Patent

TargetCyclin-dependent kinase 7(Human)
Yungjin Pharm.

US Patent
LigandChemical structure of BindingDB Monomer ID 699568BDBM699568(BDBM699584 | US12110299, Example 81)
Affinity DataIC50: 6.40nMAssay Description:Representative compounds of the present invention were assayed in vitro for CDK7 kinase-inhibitory activities using ADP-Glo platform. In detail, CDK7...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2025
Entry Details
US Patent

TargetCyclin-dependent kinase 7(Human)
Yungjin Pharm.

US Patent
LigandChemical structure of BindingDB Monomer ID 699697BDBM699697(US12110299, Example 132)
Affinity DataIC50: 6.60nMAssay Description:Representative compounds of the present invention were assayed in vitro for CDK7 kinase-inhibitory activities using ADP-Glo platform. In detail, CDK7...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2025
Entry Details
US Patent

TargetCyclin-dependent kinase 7(Human)
Yungjin Pharm.

US Patent
LigandChemical structure of BindingDB Monomer ID 699633BDBM699633(US12110299, Example 101)
Affinity DataIC50: 7nMAssay Description:Representative compounds of the present invention were assayed in vitro for CDK7 kinase-inhibitory activities using ADP-Glo platform. In detail, CDK7...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2025
Entry Details
US Patent

TargetCyclin-dependent kinase 7(Human)
Yungjin Pharm.

US Patent
LigandChemical structure of BindingDB Monomer ID 699688BDBM699688(US12110299, Example 121)
Affinity DataIC50: 7nMAssay Description:Representative compounds of the present invention were assayed in vitro for CDK7 kinase-inhibitory activities using ADP-Glo platform. In detail, CDK7...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2025
Entry Details
US Patent

TargetCyclin-dependent kinase 7(Human)
Yungjin Pharm.

US Patent
LigandChemical structure of BindingDB Monomer ID 699625BDBM699625(US12110299, Example 99)
Affinity DataIC50: 7.60nMAssay Description:Representative compounds of the present invention were assayed in vitro for CDK7 kinase-inhibitory activities using ADP-Glo platform. In detail, CDK7...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2025
Entry Details
US Patent

TargetCyclin-dependent kinase 7(Human)
Yungjin Pharm.

US Patent
LigandChemical structure of BindingDB Monomer ID 699619BDBM699619(US12110299, Example 96)
Affinity DataIC50: 7.60nMAssay Description:Representative compounds of the present invention were assayed in vitro for CDK7 kinase-inhibitory activities using ADP-Glo platform. In detail, CDK7...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2025
Entry Details
US Patent

TargetCyclin-dependent kinase 7(Human)
Yungjin Pharm.

US Patent
LigandChemical structure of BindingDB Monomer ID 699702BDBM699702(US12110299, Example 138)
Affinity DataIC50: 8nMAssay Description:Representative compounds of the present invention were assayed in vitro for CDK7 kinase-inhibitory activities using ADP-Glo platform. In detail, CDK7...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2025
Entry Details
US Patent

TargetCyclin-dependent kinase 7(Human)
Yungjin Pharm.

US Patent
LigandChemical structure of BindingDB Monomer ID 699695BDBM699695(US12110299, Example 130)
Affinity DataIC50: 8nMAssay Description:Representative compounds of the present invention were assayed in vitro for CDK7 kinase-inhibitory activities using ADP-Glo platform. In detail, CDK7...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2025
Entry Details
US Patent

TargetCyclin-dependent kinase 7(Human)
Yungjin Pharm.

US Patent
LigandChemical structure of BindingDB Monomer ID 699568BDBM699568(BDBM699584 | US12110299, Example 81)
Affinity DataIC50: 8nMAssay Description:Representative compounds of the present invention were assayed in vitro for CDK7 kinase-inhibitory activities using ADP-Glo platform. In detail, CDK7...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2025
Entry Details
US Patent

TargetCyclin-dependent kinase 7(Human)
Yungjin Pharm.

US Patent
LigandChemical structure of BindingDB Monomer ID 699651BDBM699651(US12110299, Example 109)
Affinity DataIC50: 8.20nMAssay Description:Representative compounds of the present invention were assayed in vitro for CDK7 kinase-inhibitory activities using ADP-Glo platform. In detail, CDK7...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2025
Entry Details
US Patent

TargetCyclin-dependent kinase 7(Human)
Yungjin Pharm.

US Patent
LigandChemical structure of BindingDB Monomer ID 699673BDBM699673(US12110299, Example 113)
Affinity DataIC50: 8.5nMAssay Description:Representative compounds of the present invention were assayed in vitro for CDK7 kinase-inhibitory activities using ADP-Glo platform. In detail, CDK7...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2025
Entry Details
US Patent

TargetCyclin-dependent kinase 7(Human)
Yungjin Pharm.

US Patent
LigandChemical structure of BindingDB Monomer ID 699686BDBM699686(US12110299, Example 119)
Affinity DataIC50: 9nMAssay Description:Representative compounds of the present invention were assayed in vitro for CDK7 kinase-inhibitory activities using ADP-Glo platform. In detail, CDK7...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2025
Entry Details
US Patent

TargetCyclin-dependent kinase 7(Human)
Yungjin Pharm.

US Patent
LigandChemical structure of BindingDB Monomer ID 699636BDBM699636(US12110299, Example 104)
Affinity DataIC50: 9nMAssay Description:Representative compounds of the present invention were assayed in vitro for CDK7 kinase-inhibitory activities using ADP-Glo platform. In detail, CDK7...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2025
Entry Details
US Patent

TargetCyclin-dependent kinase 7(Human)
Yungjin Pharm.

US Patent
LigandChemical structure of BindingDB Monomer ID 699661BDBM699661(US12110299, Example 111)
Affinity DataIC50: 9.5nMAssay Description:Representative compounds of the present invention were assayed in vitro for CDK7 kinase-inhibitory activities using ADP-Glo platform. In detail, CDK7...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2025
Entry Details
US Patent

TargetCyclin-dependent kinase 7(Human)
Yungjin Pharm.

US Patent
LigandChemical structure of BindingDB Monomer ID 699626BDBM699626(US12110299, Example 100)
Affinity DataIC50: 9.80nMAssay Description:Representative compounds of the present invention were assayed in vitro for CDK7 kinase-inhibitory activities using ADP-Glo platform. In detail, CDK7...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2025
Entry Details
US Patent

TargetCyclin-dependent kinase 7(Human)
Yungjin Pharm.

US Patent
LigandChemical structure of BindingDB Monomer ID 699644BDBM699644(US12110299, Example 108)
Affinity DataIC50: 10.5nMAssay Description:Representative compounds of the present invention were assayed in vitro for CDK7 kinase-inhibitory activities using ADP-Glo platform. In detail, CDK7...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2025
Entry Details
US Patent

TargetCyclin-dependent kinase 7(Human)
Yungjin Pharm.

US Patent
LigandChemical structure of BindingDB Monomer ID 699531BDBM699531(US12110299, Example 15)
Affinity DataIC50: 11nMAssay Description:Representative compounds of the present invention were assayed in vitro for CDK7 kinase-inhibitory activities using ADP-Glo platform. In detail, CDK7...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2025
Entry Details
US Patent

TargetCyclin-dependent kinase 7(Human)
Yungjin Pharm.

US Patent
LigandChemical structure of BindingDB Monomer ID 699532BDBM699532(US12110299, Example 17)
Affinity DataIC50: 11nMAssay Description:Representative compounds of the present invention were assayed in vitro for CDK7 kinase-inhibitory activities using ADP-Glo platform. In detail, CDK7...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2025
Entry Details
US Patent

TargetCyclin-dependent kinase 7(Human)
Yungjin Pharm.

US Patent
LigandChemical structure of BindingDB Monomer ID 699678BDBM699678(US12110299, Example 114)
Affinity DataIC50: 12nMAssay Description:Representative compounds of the present invention were assayed in vitro for CDK7 kinase-inhibitory activities using ADP-Glo platform. In detail, CDK7...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2025
Entry Details
US Patent

TargetCyclin-dependent kinase 7(Human)
Yungjin Pharm.

US Patent
LigandChemical structure of BindingDB Monomer ID 699634BDBM699634(US12110299, Example 102)
Affinity DataIC50: 13nMAssay Description:Representative compounds of the present invention were assayed in vitro for CDK7 kinase-inhibitory activities using ADP-Glo platform. In detail, CDK7...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2025
Entry Details
US Patent

TargetCyclin-dependent kinase 7(Human)
Yungjin Pharm.

US Patent
LigandChemical structure of BindingDB Monomer ID 699635BDBM699635(US12110299, Example 103)
Affinity DataIC50: 13nMAssay Description:Representative compounds of the present invention were assayed in vitro for CDK7 kinase-inhibitory activities using ADP-Glo platform. In detail, CDK7...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2025
Entry Details
US Patent

TargetCyclin-dependent kinase 7(Human)
Yungjin Pharm.

US Patent
LigandChemical structure of BindingDB Monomer ID 699701BDBM699701(US12110299, Example 137)
Affinity DataIC50: 13nMAssay Description:Representative compounds of the present invention were assayed in vitro for CDK7 kinase-inhibitory activities using ADP-Glo platform. In detail, CDK7...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2025
Entry Details
US Patent

TargetCyclin-dependent kinase 7(Human)
Yungjin Pharm.

US Patent
LigandChemical structure of BindingDB Monomer ID 699699BDBM699699(US12110299, Example 135)
Affinity DataIC50: 13nMAssay Description:Representative compounds of the present invention were assayed in vitro for CDK7 kinase-inhibitory activities using ADP-Glo platform. In detail, CDK7...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2025
Entry Details
US Patent

TargetCyclin-dependent kinase 7(Human)
Yungjin Pharm.

US Patent
LigandChemical structure of BindingDB Monomer ID 699683BDBM699683(US12110299, Example 116)
Affinity DataIC50: 13nMAssay Description:Representative compounds of the present invention were assayed in vitro for CDK7 kinase-inhibitory activities using ADP-Glo platform. In detail, CDK7...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2025
Entry Details
US Patent

TargetCyclin-dependent kinase 7(Human)
Yungjin Pharm.

US Patent
LigandChemical structure of BindingDB Monomer ID 699692BDBM699692(US12110299, Example 125)
Affinity DataIC50: 13nMAssay Description:Representative compounds of the present invention were assayed in vitro for CDK7 kinase-inhibitory activities using ADP-Glo platform. In detail, CDK7...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2025
Entry Details
US Patent

TargetCyclin-dependent kinase 7(Human)
Yungjin Pharm.

US Patent
LigandChemical structure of BindingDB Monomer ID 699601BDBM699601(US12110299, Example 94)
Affinity DataIC50: 14nMAssay Description:Representative compounds of the present invention were assayed in vitro for CDK7 kinase-inhibitory activities using ADP-Glo platform. In detail, CDK7...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2025
Entry Details
US Patent

TargetCyclin-dependent kinase 7(Human)
Yungjin Pharm.

US Patent
LigandChemical structure of BindingDB Monomer ID 699684BDBM699684(US12110299, Example 117)
Affinity DataIC50: 15nMAssay Description:Representative compounds of the present invention were assayed in vitro for CDK7 kinase-inhibitory activities using ADP-Glo platform. In detail, CDK7...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2025
Entry Details
US Patent

TargetCyclin-dependent kinase 7(Human)
Yungjin Pharm.

US Patent
LigandChemical structure of BindingDB Monomer ID 699687BDBM699687(US12110299, Example 120)
Affinity DataIC50: 16nMAssay Description:Representative compounds of the present invention were assayed in vitro for CDK7 kinase-inhibitory activities using ADP-Glo platform. In detail, CDK7...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2025
Entry Details
US Patent

TargetCyclin-dependent kinase 7(Human)
Yungjin Pharm.

US Patent
LigandChemical structure of BindingDB Monomer ID 699574BDBM699574(US12110299, Example 88)
Affinity DataIC50: 16nMAssay Description:Representative compounds of the present invention were assayed in vitro for CDK7 kinase-inhibitory activities using ADP-Glo platform. In detail, CDK7...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2025
Entry Details
US Patent

TargetCyclin-dependent kinase 7(Human)
Yungjin Pharm.

US Patent
LigandChemical structure of BindingDB Monomer ID 699682BDBM699682(US12110299, Example 115)
Affinity DataIC50: 17nMAssay Description:Representative compounds of the present invention were assayed in vitro for CDK7 kinase-inhibitory activities using ADP-Glo platform. In detail, CDK7...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2025
Entry Details
US Patent

TargetCyclin-dependent kinase 7(Human)
Yungjin Pharm.

US Patent
LigandChemical structure of BindingDB Monomer ID 699545BDBM699545(US12110299, Example 63)
Affinity DataIC50: 17nMAssay Description:Representative compounds of the present invention were assayed in vitro for CDK7 kinase-inhibitory activities using ADP-Glo platform. In detail, CDK7...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2025
Entry Details
US Patent

TargetCyclin-dependent kinase 7(Human)
Yungjin Pharm.

US Patent
LigandChemical structure of BindingDB Monomer ID 699537BDBM699537(US12110299, Example 37)
Affinity DataIC50: 17nMAssay Description:Representative compounds of the present invention were assayed in vitro for CDK7 kinase-inhibitory activities using ADP-Glo platform. In detail, CDK7...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2025
Entry Details
US Patent

TargetCyclin-dependent kinase 7(Human)
Yungjin Pharm.

US Patent
LigandChemical structure of BindingDB Monomer ID 699694BDBM699694(US12110299, Example 129)
Affinity DataIC50: 17nMAssay Description:Representative compounds of the present invention were assayed in vitro for CDK7 kinase-inhibitory activities using ADP-Glo platform. In detail, CDK7...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2025
Entry Details
US Patent

TargetCyclin-dependent kinase 7(Human)
Yungjin Pharm.

US Patent
LigandChemical structure of BindingDB Monomer ID 699663BDBM699663(US12110299, Example 112)
Affinity DataIC50: 17nMAssay Description:Representative compounds of the present invention were assayed in vitro for CDK7 kinase-inhibitory activities using ADP-Glo platform. In detail, CDK7...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2025
Entry Details
US Patent

TargetCyclin-dependent kinase 7(Human)
Yungjin Pharm.

US Patent
LigandChemical structure of BindingDB Monomer ID 699539BDBM699539(US12110299, Example 52)
Affinity DataIC50: 19nMAssay Description:Representative compounds of the present invention were assayed in vitro for CDK7 kinase-inhibitory activities using ADP-Glo platform. In detail, CDK7...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2025
Entry Details
US Patent

TargetCyclin-dependent kinase 7(Human)
Yungjin Pharm.

US Patent
LigandChemical structure of BindingDB Monomer ID 699685BDBM699685(US12110299, Example 118)
Affinity DataIC50: 20nMAssay Description:Representative compounds of the present invention were assayed in vitro for CDK7 kinase-inhibitory activities using ADP-Glo platform. In detail, CDK7...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2025
Entry Details
US Patent

TargetCyclin-dependent kinase 7(Human)
Yungjin Pharm.

US Patent
LigandChemical structure of BindingDB Monomer ID 699538BDBM699538(US12110299, Example 45)
Affinity DataIC50: 22nMAssay Description:Representative compounds of the present invention were assayed in vitro for CDK7 kinase-inhibitory activities using ADP-Glo platform. In detail, CDK7...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2025
Entry Details
US Patent

TargetCyclin-dependent kinase 7(Human)
Yungjin Pharm.

US Patent
LigandChemical structure of BindingDB Monomer ID 699571BDBM699571(US12110299, Example 83)
Affinity DataIC50: 23nMAssay Description:Representative compounds of the present invention were assayed in vitro for CDK7 kinase-inhibitory activities using ADP-Glo platform. In detail, CDK7...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2025
Entry Details
US Patent

TargetCyclin-dependent kinase 7(Human)
Yungjin Pharm.

US Patent
LigandChemical structure of BindingDB Monomer ID 699506BDBM699506(US12110299, Example 14)
Affinity DataIC50: 28nMAssay Description:Representative compounds of the present invention were assayed in vitro for CDK7 kinase-inhibitory activities using ADP-Glo platform. In detail, CDK7...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2025
Entry Details
US Patent

TargetCyclin-dependent kinase 7(Human)
Yungjin Pharm.

US Patent
LigandChemical structure of BindingDB Monomer ID 699639BDBM699639(US12110299, Example 107)
Affinity DataIC50: 31nMAssay Description:Representative compounds of the present invention were assayed in vitro for CDK7 kinase-inhibitory activities using ADP-Glo platform. In detail, CDK7...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2025
Entry Details
US Patent

TargetCyclin-dependent kinase 7(Human)
Yungjin Pharm.

US Patent
LigandChemical structure of BindingDB Monomer ID 699700BDBM699700(US12110299, Example 136)
Affinity DataIC50: 33nMAssay Description:Representative compounds of the present invention were assayed in vitro for CDK7 kinase-inhibitory activities using ADP-Glo platform. In detail, CDK7...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2025
Entry Details
US Patent

TargetCyclin-dependent kinase 7(Human)
Yungjin Pharm.

US Patent
LigandChemical structure of BindingDB Monomer ID 699504BDBM699504(US12110299, Example 6)
Affinity DataIC50: 35nMAssay Description:Representative compounds of the present invention were assayed in vitro for CDK7 kinase-inhibitory activities using ADP-Glo platform. In detail, CDK7...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2025
Entry Details
US Patent

TargetCyclin-dependent kinase 7(Human)
Yungjin Pharm.

US Patent
LigandChemical structure of BindingDB Monomer ID 699569BDBM699569(US12110299, Example 82)
Affinity DataIC50: 36nMAssay Description:Representative compounds of the present invention were assayed in vitro for CDK7 kinase-inhibitory activities using ADP-Glo platform. In detail, CDK7...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2025
Entry Details
US Patent

TargetCyclin-dependent kinase 7(Human)
Yungjin Pharm.

US Patent
LigandChemical structure of BindingDB Monomer ID 699498BDBM699498(US12110299, Example 2)
Affinity DataIC50: 40nMAssay Description:Representative compounds of the present invention were assayed in vitro for CDK7 kinase-inhibitory activities using ADP-Glo platform. In detail, CDK7...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2025
Entry Details
US Patent

TargetCyclin-dependent kinase 7(Human)
Yungjin Pharm.

US Patent
LigandChemical structure of BindingDB Monomer ID 699587BDBM699587(US12110299, Example 92)
Affinity DataIC50: 42nMAssay Description:Representative compounds of the present invention were assayed in vitro for CDK7 kinase-inhibitory activities using ADP-Glo platform. In detail, CDK7...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2025
Entry Details
US Patent

TargetCyclin-dependent kinase 7(Human)
Yungjin Pharm.

US Patent
LigandChemical structure of BindingDB Monomer ID 699551BDBM699551(US12110299, Example 73)
Affinity DataIC50: 43nMAssay Description:Representative compounds of the present invention were assayed in vitro for CDK7 kinase-inhibitory activities using ADP-Glo platform. In detail, CDK7...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2025
Entry Details
US Patent

Displayed 1 to 50 (of 60 total ) | Next | Last >>
Jump to: